M Ansar, CJ Wang, YH Wang, TH Shen… - International journal of …, 2020 - mdpi.com
The incidence and mortality rates of colorectal cancer (CRC) have been high in recent years. Prevention and early detection are crucial for decreasing the death rate. Therefore …
In a recent clinical trial, the metabolite l-glutamine was shown to reduce painful crises in sickle cell disease (SCD) patients. To support this observation and identify other metabolites …
Phosphatidate phosphatase‐1 (lipin‐1) is encoded by LPIN1 gene. Lipin‐1 deficiency has been reported as the second most common cause of early‐onset rhabdomyolysis after …
T Minton, N Forrester, S Al Baba, K Urankar… - Neuromuscular …, 2020 - Elsevier
Pathogenic variants in LPIN1 are a recognised cause of severe and often fatal rhabdomyolysis in childhood. We present a rare case of adult onset recurrent …
Background LPIN1-related acute recurrent rhabdomyolysis (RM), first reported in 2008, is an autosomal recessive inherited metabolic disease. In recent years, LPIN1 gene variants have …
Sickle cell disease is a monogenic disorder caused by a point mutation in the beta-globin gene. The complications related to the disease are characterized by a broad spectrum of …
K Tong, GS Yu - 2021 - bmcneurol.biomedcentral.com
Background: LPIN1-related acute recurrent rhabdomyolysis (RM), first reported in 2008, is an autosomal recessive inherited metabolic disease. In recent years, LPIN1 gene variants …
Phosphatidate phosphatase-1 (lipin-1) is encoded by LPIN1 gene. Lipin-1 deficiency has been reported as the second most common cause of early-onset rhabdomyolysis after …
L Pons, C Acquaviva-Bourdain, S Teyssedre… - Molecular …, 2020 - karger.com
LPIN1 molecular alterations were identified as a major cause of severe recurrent rhabdomyolysis. The prognosis is poor, with a third of patients dying from cardiac arrest …